Tapewire

Nasdaq · USD

SANA

Sana Biotechnology, Inc.

Export transactions ↓
Tapewire entity
4870
SEC CIK
0001770121
Parsed reports
193

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 03, 2021 Filed Feb 5, 2021 17:20 UTC
AGARWAL SUNILSee Remarks
GrantStock Option (Right to Buy) · Derivative 48,000 $0.00 Strike: $25.00 $0.00
Disclosure

SEC source: 0000899243-21-005080 · doc4.xml · derivative · entry 1

AGARWAL SUNIL · CIK 0001616640 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,000

Underlying: Common Stock · 48,000 shares

Expires 2031-02-02

F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on February 15, 2022 and in 36 equal monthly installments thereafter.

Read SEC document
February 03, 2021 Filed Feb 5, 2021 22:15 UTC
REICIN ALISEDirector
GrantStock Option (Right to Buy) · Derivative 7,000 $0.00 Strike: $25.00 $0.00
Disclosure

SEC source: 0000899243-21-005067 · doc4.xml · derivative · entry 1

REICIN ALISE · CIK 0001757533 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,000

Underlying: Common Stock · 7,000 shares

Expires 2031-02-02

F1 · derivative.exercise_date: The stock option shall vest and become exercisable in full on February 3, 2022.

Read SEC document
February 03, 2021 Filed Feb 5, 2021 17:22 UTC GrantStock Option (Right to Buy) · Derivative 14,000 $0.00 Strike: $25.00 $0.00
Disclosure

SEC source: 0000899243-21-005083 · doc4.xml · derivative · entry 1

von Maltzahn Geoffrey · CIK 0001768286 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,000

Underlying: Common Stock · 14,000 shares

Expires 2031-02-02

F1 · derivative.exercise_date: The stock option shall vest and become exercisable in full on February 3, 2022.

Read SEC document
February 03, 2021 Filed Feb 5, 2021 22:15 UTC GrantStock Option (Right to Buy) · Derivative 7,000 $0.00 Strike: $25.00 $0.00
Disclosure

SEC source: 0000899243-21-005069 · doc4.xml · derivative · entry 1

Seitz Michelle · CIK 0001836301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,000

Underlying: Common Stock · 7,000 shares

Expires 2031-02-02

F1 · derivative.exercise_date: The stock option shall vest and become exercisable in full on February 3, 2022.

Read SEC document
February 03, 2021 Filed Feb 18, 2021 23:59 UTC Amendment GrantStock Option (Right to Buy) · Derivative 23,591 $0.00 Strike: $25.00 $0.00
Disclosure

SEC source: 0000899243-21-007193 · doc4a.xml · derivative · entry 1

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,591

Underlying: Common Stock · 23,591 shares

Expires 2031-02-02

F1 · shares: This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired.

F2 · derivative.exercise_date: The stock option shall vest and become exercisable in full on February 3, 2022.

F1 · derivative.underlying_shares: This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired.

F1 · balance_after: This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired.

Read SEC document
February 03, 2021 Filed Feb 18, 2021 23:59 UTC Amendment GrantStock Option (Right to Buy) · Derivative 11,795 $0.00 Strike: $25.00 $0.00
Disclosure

SEC source: 0000899243-21-007194 · doc4a.xml · derivative · entry 1

Bilenker Joshua H. · CIK 0001612312 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,795

Underlying: Common Stock · 11,795 shares

Expires 2031-02-02

F1 · shares: This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired.

F2 · derivative.exercise_date: The stock option shall vest and become exercisable in full on February 3, 2022.

F1 · derivative.underlying_shares: This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired.

F1 · balance_after: This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired.

Read SEC document
February 03, 2021 Filed Feb 18, 2021 23:58 UTC Amendment GrantStock Option (Right to Buy) · Derivative 23,591 $0.00 Strike: $25.00 $0.00
Disclosure

SEC source: 0000899243-21-007191 · doc4a.xml · derivative · entry 1

Cole Douglas G. · CIK 0001486373 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,591

Underlying: Common Stock · 23,591 shares

Expires 2031-02-02

F1 · shares: This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired.

F2 · derivative.exercise_date: The stock option shall vest and become exercisable in full on February 3, 2022.

F1 · derivative.underlying_shares: This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired.

F1 · balance_after: This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired.

Read SEC document
February 03, 2021 Filed Feb 19, 2021 00:02 UTC Amendment GrantStock Option (Right to Buy) · Derivative 23,591 $0.00 Strike: $25.00 $0.00
Disclosure

SEC source: 0000899243-21-007197 · doc4a.xml · derivative · entry 1

Bishop Hans Edgar · CIK 0001480212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,591

Underlying: Common Stock · 23,591 shares

Expires 2031-02-02

F1 · shares: This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired.

F2 · derivative.exercise_date: The stock option shall vest and become exercisable in full on February 3, 2022.

F1 · derivative.underlying_shares: This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired.

F1 · balance_after: This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired.

Read SEC document
February 03, 2021 Filed Feb 18, 2021 23:56 UTC Amendment GrantStock Option (Right to Buy) · Derivative 23,591 $0.00 Strike: $25.00 $0.00
Disclosure

SEC source: 0000899243-21-007187 · doc4a.xml · derivative · entry 1

NELSEN ROBERT · CIK 0001219042 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,591

Underlying: Common Stock · 23,591 shares

Expires 2031-02-02

F1 · shares: This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired.

F2 · derivative.exercise_date: The stock option shall vest and become exercisable in full on February 3, 2022.

F1 · derivative.underlying_shares: This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired.

F1 · balance_after: This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired.

Read SEC document
February 03, 2021 Filed Feb 18, 2021 23:54 UTC Amendment GrantStock Option (Right to Buy) · Derivative 23,591 $0.00 Strike: $25.00 $0.00
Disclosure

SEC source: 0000899243-21-007185 · doc4a.xml · derivative · entry 1

Yang Patrick Y · CIK 0001309988 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,591

Underlying: Common Stock · 23,591 shares

Expires 2031-02-02

F1 · shares: This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired.

F2 · derivative.exercise_date: The stock option shall vest and become exercisable in full on February 3, 2022.

F1 · derivative.underlying_shares: This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired.

F1 · balance_after: This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired.

Read SEC document
February 03, 2021 Filed Feb 18, 2021 18:50 UTC Amendment
AGARWAL SUNILSee Remarks
GrantStock Option (Right to Buy) · Derivative 76,682 $0.00 Strike: $25.00 $0.00
Disclosure

SEC source: 0000899243-21-007181 · doc4a.xml · derivative · entry 1

AGARWAL SUNIL · CIK 0001616640 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,682

Underlying: Common Stock · 76,682 shares

Expires 2031-02-02

F1 · shares: This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired.

F2 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on February 15, 2022 and in 36 equal monthly installments thereafter.

F1 · derivative.underlying_shares: This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired.

F1 · balance_after: This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired.

Read SEC document
February 03, 2021 Filed Feb 18, 2021 23:59 UTC Amendment
REICIN ALISEDirector
GrantStock Option (Right to Buy) · Derivative 11,795 $0.00 Strike: $25.00 $0.00
Disclosure

SEC source: 0000899243-21-007195 · doc4a.xml · derivative · entry 1

REICIN ALISE · CIK 0001757533 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,795

Underlying: Common Stock · 11,795 shares

Expires 2031-02-02

F1 · shares: This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired.

F2 · derivative.exercise_date: The stock option shall vest and become exercisable in full on February 3, 2022.

F1 · derivative.underlying_shares: This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired.

F1 · balance_after: This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired.

Read SEC document
February 03, 2021 Filed Feb 18, 2021 19:04 UTC Amendment GrantStock Option (Right to Buy) · Derivative 23,591 $0.00 Strike: $25.00 $0.00
Disclosure

SEC source: 0000899243-21-007199 · doc4a.xml · derivative · entry 1

von Maltzahn Geoffrey · CIK 0001768286 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,591

Underlying: Common Stock · 23,591 shares

Expires 2031-02-02

F1 · shares: This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired.

F2 · derivative.exercise_date: The stock option shall vest and become exercisable in full on February 3, 2022.

F1 · derivative.underlying_shares: This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired.

F1 · balance_after: This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired.

Read SEC document
February 03, 2021 Filed Feb 18, 2021 23:54 UTC Amendment GrantStock Option (Right to Buy) · Derivative 11,795 $0.00 Strike: $25.00 $0.00
Disclosure

SEC source: 0000899243-21-007184 · doc4a.xml · derivative · entry 1

Seitz Michelle · CIK 0001836301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,795

Underlying: Common Stock · 11,795 shares

Expires 2031-02-02

F1 · shares: This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired.

F2 · derivative.exercise_date: The stock option shall vest and become exercisable in full on February 3, 2022.

F1 · derivative.underlying_shares: This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired.

F1 · balance_after: This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired.

Read SEC document
February 03, 2021 Filed Feb 17, 2023 22:17 UTC PurchaseCommon Stock 20,000 $25.00 $500,000.00
Disclosure

SEC source: 0001562180-23-001518 · primarydocument.xml · nonDerivative · entry 1

Bilenker Joshua H. · CIK 0001612312 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.